EUVIMEDEUVIMED entdecken
Crossref

Epidemiología molecular del virus del papiloma humano en el tamizajedel cáncer cervicouterino en Córdoba, Argentina

Franco Cippitelli, María Elisa Rivarola, Paola Sicilia, Facundo Cuba, Tomás Poklépovich, María Gabriela Barbás, Gonzalo Manuel Castro, Silvia María Eugenia Kademian

Revista Bioquímica y Patología Clínica · 19.08.2025 · 89 (3) · 44-51

DOI: 10.62073/b49c6v14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Bioquímica y Patología Clínica, online erschienen am 19.08.2025. Verfasst von Franco Cippitelli und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular assays followed by cytology in Human Papillomavirus (HPV)-positive women provide a significant increase in sensitivity and specificity in the early detection of cervical neoplasia. Objectives: a) to evaluate the results of the “Cobas 4800 HPV Test” (Roche), introduced as a primary screening strategy for cervical cancer into the local algorithms; and b) to characterize the distribution of genotypes using massive sequencing techniques. Materials and Methods: A total of 3685 women between 30 and 64 years of age with unknown cervical pathology were screened. Samples were collected for HPV testing and cytology as a triage test. HPV-positive samples were further analyzed by massive parallel sequencing.

Results

The overall positivity for high-risk HPV was 12.6% (464/3685). Among the positive samples, HPV 16 and 18 were present in simple or combined infections in 20.7% (96/434) and 13.8% (64/434) of the cases, respectively, whereas exclusively high-risk HPV genotypes other than HPV 16 and 18 were present in 72.8% (338/464) of the cases.

Conclusions

The commercial assay used allowed partial genotyping, particularly enabling risk stratification and prioritizing clinical decision making in women positive for HPV 16 and 18. The routine implementation of extended genotyping through massive sequencing will allow facing new challenges in addressing the molecular epidemiology of HPV.

Zitieren

APA

Cippitelli, F., Rivarola, M. E., Sicilia, P., Cuba, F., Poklépovich, T., Barbás, M. G., Castro, G. M., & Kademian, S. M. E. (2025). Epidemiología molecular del virus del papiloma humano en el tamizajedel cáncer cervicouterino en Córdoba, Argentina. Revista Bioquímica y Patología Clínica, 89(3), 44-51. https://doi.org/10.62073/b49c6v14

Vancouver

Cippitelli F, Rivarola ME, Sicilia P, Cuba F, Poklépovich T, Barbás MG, et al. Epidemiología molecular del virus del papiloma humano en el tamizajedel cáncer cervicouterino en Córdoba, Argentina. Revista Bioquímica y Patología Clínica. 2025;89(3):44-51. doi:10.62073/b49c6v14

BibTeX
@article{Cippitelli2025,
  author = {Cippitelli, Franco and Rivarola, María Elisa and Sicilia, Paola and Cuba, Facundo and Poklépovich, Tomás and Barbás, María Gabriela and Castro, Gonzalo Manuel and Kademian, Silvia María Eugenia},
  title = {Epidemiología molecular del virus del papiloma humano en el tamizajedel cáncer cervicouterino en Córdoba, Argentina},
  journal = {Revista Bioquímica y Patología Clínica},
  year = {2025},
  volume = {89},
  number = {3},
  pages = {44--51},
  doi = {10.62073/b49c6v14}
}
Kostenlos starten →